Substituted oxazolidinones and their use

US8487111B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Swen Allerheiligen · Wuppertal, DE
• Marcus Bauser · Berlin, DE
• Hartmut Schirok · Wuppertal, DE
• Ulrich Rester · Wuppertal, DE
• Stefan Heitmeier · Wülfrath, DE
• Christoph Gerdes
• Georges Von Degenfeld · Leverkusen, DE
• Elke Dittrich-Wengenroth · Wuppertal, DE
• Uwe Saatmann · Wuppertal, DE
• Julia STRAßBURGER · Wuppertal, DE
• Klaus Münter · Mannheim, DE
• Mark Jean Gnoth · Mettmann, DE
• Dieter Lang · Velbert, DE

Key dates

• Filing date: Jun 7, 2008
• Grant date: Jul 16, 2013
• Expiry date: Jun 11, 2028

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to novel substituted oxazolidinones, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of thromboembolic disorders.